Such "countdown demonstration tests" have traditionally taken place shortly before launch with the rocket and crew ship ...

According to Anand Kannappan, CEO and co-founder of Patronus AI, for agents to perform tasks at human-comparable levels, they ...

Patronus AI today announced "Generative Simulators," adaptive simulation environments that can continually create new tasks and scenarios, update the rules of the world in a simulation environment, ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...